Fig. 2

Sequencing analysis of CRISPR/Cas9-mediated TP53 knockout (KO) canine fatal fibroblasts. a Nucleotide sequences of targeted TP53 genomic loci of cells treated with TP53 gRNA #30 (colonies #2, #10, and #11) and b TP53 gRNA #39 (colonies #3, #5, and #6)